Works matching IS 14611457 AND DT 2005 AND VI 8 AND IP 3

Results: 19

Association analysis of NAD(P)H:quinone oxidoreductase (NQO1) Pro187Ser genetic polymorphism and tardive dyskinesia in patients with schizophrenia in Taiwan.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 483, doi. 10.1017/s1461145705005262

By:

Ying-Jay Liou;
Ying-Chieh Wang;
Chao-Cheng Lin;
Ya-Mei Bai;
I-Ching Lai;
Ding-Lieh Liao;
Jen-Yeu Chen

Publication type:

Article

Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 411, doi. 10.1017/s1461145705005389

By:

Bernard Lerer;
Ronnen H. Segman;
Ene-Choo Tan;
Vincenzo S. Basile;
Roberto Cavallaro;
Harald N. Aschauer;
Rael Strous;
Siow-Ann Chong;
Uriel Heresco-Levy;
Massimiliano Verga;
Joachim Scharfetter;
Herbert Y. Meltzer;
James L. Kennedy;
Fabio Macciardi

Publication type:

Article

Case series on the use of aripiprazole for Tourette syndrome.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 489, doi. 10.1017/s1461145705005365

By:

Tanya K. Murphy;
Michael A. Bengtson;
Ohel Soto;
Paula J. Edge;
Muhammad W. Sajid;
Nathan Shapira;
Mark Yang

Publication type:

Article

Combined a2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 315, doi. 10.1017/s1461145705005328

By:

Monica M. Marcus;
Kent E. Jardemark;
Marie-Louise Wadenberg;
Xavier Langlois;
Peter Hertel;
Torgny H. Svensson

Publication type:

Article

Psychosis as a possible side-effect of treatment with glatiramer acetate.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 487, doi. 10.1017/s1461145705005304

By:

Edda Pjrek;
Dietmar Winkler;
Kanita Dervic;
Harald Aschauer;
Siegfried Kasper

Publication type:

Article

Focus on Clozapine: a new explanation for its atypical character.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 311, doi. 10.1017/s1461145705005390

By:

Pierre Sokoloff

Publication type:

Article

Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 439, doi. 10.1017/s1461145705005249

By:

Taylor Moran-Gates;
Kehong Zhang;
Ross J. Baldessarini;
Frank I. Tarazi

Publication type:

Article

Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 451, doi. 10.1017/s1461145705005237

By:

Tomiki Sumiyoshi;
Dai Jin;
Karu Jayathilake;
Myung Lee;
Herbert Y. Meltzer

Publication type:

Article

Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 427, doi. 10.1017/s1461145705005225

By:

Robert A. Lasser;
Cynthia A. Bossie;
Georges M. Gharabawi;
Ross J. Baldessarini

Publication type:

Article

Evidence-based pharmacotherapy of panic disorder.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 473, doi. 10.1017/s1461145705005201

By:

Abraham Bakker;
Anton J. L. M. van Balkom;
Dan J. Stein

Publication type:

Article

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 457, doi. 10.1017/s146114570500516x

By:

Neil D. Woodward;
Scot E. Purdon;
Herbert Y. Meltzer;
David H. Zald

Publication type:

Article

Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 403, doi. 10.1017/s1461145705005158

By:

Georg Nikisch;
Hans gren;
Chin B. Eap;
Adelheid Czernik;
Pierre Baumann;
Aleksander A. Math

Publication type:

Article

Study of mirtazapine antidepressant effects in rats.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 369, doi. 10.1017/s1461145705005146

By:

Riccardo Rauggi;
Anna Cassanelli;
Anna Raone;
Alessandro Tagliamonte;
Carla Gambarana

Publication type:

Article

Expression of Ndrg2 in the rat frontal cortex after antidepressant and electroconvulsive treatment.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 381, doi. 10.1017/s1461145705005134

By:

Kou Takahashi;
Misa Yamada;
Hisayuki Ohata;
Kazutaka Momose;
Teruhiko Higuchi;
Kazuo Honda;
Mitsuhiko Yamada

Publication type:

Article

The antidepressant effect of running is associated with increased hippocampal cell proliferation.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 357, doi. 10.1017/s1461145705005122

By:

Astrid Bjrnebekk;
Aleksander A. Math;
Stefan Bren

Publication type:

Article

Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 329, doi. 10.1017/s1461145705005080

By:

Linda K. Nilsson;
Lilly Schwieler;
Gran Engberg;
Klas R. Linderholm;
Sophie Erhardt

Publication type:

Article

Bupropion SR for the treatment of postpartum depression: a pilot study.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 445, doi. 10.1017/s1461145705005079

By:

Ruta M. Nonacs;
Claudio N. Soares;
Adele C. Viguera;
Kimberly Pearson;
Jennifer R. Poitras;
Lee S. Cohen

Publication type:

Article

Patients with obsessivecompulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 391, doi. 10.1017/s1461145705005055

By:

Karen H. Adams;
Elsebeth S. Hansen;
Lars H. Pinborg;
Steen G. Hasselbalch;
Claus Svarer;
Sren Holm;
Tom G. Bolwig;
Gitte M. Knudsen

Publication type:

Article

Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 341, doi. 10.1017/s1461145704005000

By:

Adrian Newman-Tancredi;
Marie-Bernadette Assi;
Nathalie Leduc;
Anne-Marie Ormire;
Nathalie Danty;
Cristina Cosi

Publication type:

Article